Avantax Planning Partners, Inc. Alkermes Plc. Transaction History

Avantax Planning Partners, Inc.

  • $2.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$27.94 - $44.61 $1,564 - $2,498
-56 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$38.6 - $46.12 $2,161 - $2,582
56 New
56 $2,000
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $5,800 - $7,344
-143 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$53.61 - $67.26 $7,666 - $9,618
143 New
143 $8,000

Others Institutions Holding ALKS

# of Institutions
358
Shares Held
180M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.22B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email